| 08:00 - 10:20 | 33 | Educational skills workshop 1: Endoscopic lung volume reduction and endosonography | Educational Workshop |
| 08:30 - 10:30 | 34 | Paediatric Grand Round: an interactive session | Grand round |
| 08:30 - 10:30 | 35 | Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description | Hot topics |
| 08:30 - 10:30 | 36 | "Liaisons Dangereuses": the lung and other organs | Symposium |
| 08:30 - 10:30 | 37 | Highlights from ESCAPE | Symposium |
| 08:30 - 10:30 | 38 | Strengths and limitations of six-minute walk tests in chronic respiratory disease | Symposium |
| 08:30 - 10:30 | 39 | The management of N2 disease in non-small cell lung cancer | Symposium |
| 08:30 - 10:30 | 40 | Guidelines and exacerbations | Oral Presentation |
| 08:30 - 10:30 | 41 | New bronchodilators for COPD management | Oral Presentation |
| 08:30 - 10:30 | 42 | Drug-resistant tuberculosis: new clinical and public health insights | Oral Presentation |
| 08:30 - 10:30 | 43 | Lung surgery: preoperative assessment and postoperative outcome | Oral Presentation |
| 08:30 - 10:30 | 44 | Functional imaging of the lung, airways and diaphragm | Oral Presentation |
| 08:30 - 10:30 | 45 | The kaleidoscope of respiratory nursing | Oral Presentation |
| 08:30 - 10:30 | 46 | Cutting edge: drug delivery to the airways | Oral Presentation |
| 08:30 - 10:30 | 47 | Structural and functional imaging discussion: sometimes different but always linked | Poster Discussion |
| 08:30 - 10:30 | 48 | Translational studies in chronic lung diseases: from bedside to bench | Poster Discussion |
| 08:30 - 10:30 | 49 | Quality of diagnosis and assessment in primary care | Poster Discussion |
| 08:30 - 10:30 | 50 | Health economics of airway diseases | Poster Discussion |
| 08:30 - 10:30 | 51 | Pneumonia and sepsis | Poster Discussion |
| 08:30 - 10:30 | 52 | Heart, blood and metabolism in sleep disordered breathing | Poster Discussion |
| 10:45 - 12:45 | 54 | Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea” | Session |
| 10:45 - 12:45 | 55 | Inhaled corticosteroids for asthma: on-demand or continuous use? | Symposium |
| 10:45 - 12:45 | 56 | Inflammasomes in lung diseases | Symposium |
| 10:45 - 12:45 | 57 | Physical activity as the panacea for COPD | Symposium |
| 10:45 - 12:45 | 58 | Drug delivery to the airways | Symposium |
| 10:45 - 12:45 | 59 | New understanding of pneumococcal vaccination | Symposium |
| 10:45 - 12:45 | 60 | Is it really asthma? | Oral Presentation |
| 10:45 - 12:45 | 61 | New insights into mechanisms of lung allograft dysfunction | Oral Presentation |
| 10:45 - 12:45 | 62 | Advances in the therapy of lung cancer | Oral Presentation |
| 10:45 - 12:45 | 63 | Pulmonary infection in children: diagnosis and long-term effects | Oral Presentation |
| 10:45 - 12:45 | 64 | Experimental models in critical care | Oral Presentation |
| 10:45 - 12:45 | 65 | Biomarkers in asthma and COPD | Oral Presentation |
| 10:45 - 12:45 | 66 | From air pollution during pregnancy to respiratory diseases at work | Oral Presentation |
| 10:45 - 12:45 | 67 | Novel biomarkers and old parameters in clinical management of lung diseases | Poster Discussion |
| 10:45 - 12:45 | 68 | TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy | Poster Discussion |
| 10:45 - 12:45 | 69 | Oncological thoracic surgery | Poster Discussion |
| 10:45 - 12:45 | 70 | Idiopathic pulmonary fibrosis and rarities | Poster Discussion |
| 10:45 - 12:45 | 71 | Pulmonary circulation: animal models and experimental treatments | Poster Discussion |
| 10:45 - 12:45 | 72 | Tuberculosis diagnosis | Poster Discussion |
| 12:50 - 14:40 | 73 | Novel in vitro and animal models to study lung diseases | Thematic Poster Session |
| 12:50 - 14:40 | 74 | Translational research to bridge the need within clinical decision making | Thematic Poster Session |
| 12:50 - 14:40 | 75 | Airway smooth muscle and cell biology | Thematic Poster Session |
| 12:50 - 14:40 | 76 | Asthma: new mechanisms and markers | Thematic Poster Session |
| 12:50 - 14:40 | 77 | COPD: new markers of diseases | Thematic Poster Session |
| 12:50 - 14:40 | 78 | COPD: experimental biology | Thematic Poster Session |
| 12:50 - 14:40 | 79 | The vulnerable patient and ageing cells | Thematic Poster Session |
| 12:50 - 14:40 | 80 | Novel mechanisms in lung injury | Thematic Poster Session |
| 12:50 - 14:40 | 81 | Preclinical models for the development of new drugs for respiratory diseases | Thematic Poster Session |
| 12:50 - 14:40 | 82 | Asthma and COPD drugs: efficacy, safety and pharmacoeconomics | Thematic Poster Session |
| 12:50 - 14:40 | 83 | Novel pharmacological findings in the management of respiratory disorders | Thematic Poster Session |
| 12:50 - 14:40 | 84 | Novel drugs and biomarkers in respiratory medicine | Thematic Poster Session |
| 12:50 - 14:40 | 85 | Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD | Thematic Poster Session |
| 12:50 - 14:40 | 86 | Predictors and triggers of asthma and COPD exacerbations | Thematic Poster Session |
| 12:50 - 14:40 | 87 | Monitoring lung function in airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 88 | Disease control and quality of life in airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 89 | Systemic and airway biomarkers in respiratory diseases | Thematic Poster Session |
| 12:50 - 14:40 | 90 | Asthma | Thematic Poster Session |
| 12:50 - 14:40 | 91 | Cell biology and murine models of asthma and inflammation | Thematic Poster Session |
| 12:50 - 14:40 | 92 | Genetics and mechanisms of, and tests for, allergy | Thematic Poster Session |
| 12:50 - 14:40 | 93 | Treatment of asthma | Thematic Poster Session |
| 12:50 - 14:40 | 94 | Assessing the prevalence of COPD in the general population | Thematic Poster Session |
| 12:50 - 14:40 | 95 | Treatment and adherence to treatment of respiratory disease | Thematic Poster Session |
| 12:50 - 14:40 | 96 | Epidemiology of asthma | Thematic Poster Session |
| 12:50 - 14:40 | 97 | Occupational respiratory diseases: obstructive, interstitial lung diseases and methods of diagnosis | Thematic Poster Session |
| 12:50 - 14:40 | 98 | Outdoor and indoor environment: respiratory diseases from asthma to asbestosis | Thematic Poster Session |
| 12:50 - 14:40 | 99 | World tour of tobacco epidemiology | Thematic Poster Session |
| 12:50 - 14:40 | 100 | E-cigarettes, shisha, the tobacco industry and public health | Thematic Poster Session |
| 12:50 - 14:40 | 101 | Passive smoking, children and students (young adults) | Thematic Poster Session |
| 12:50 - 14:40 | 102 | Clinical applications of respiratory physiology in children | Thematic Poster Session |
| 12:50 - 14:40 | 103 | Monitoring asthma: genes, cells and molecules | Thematic Poster Session |
| 12:50 - 14:40 | 104 | Uncontrolled and severe asthma in children | Thematic Poster Session |
| 12:50 - 14:40 | 105 | Preschool wheeze | Thematic Poster Session |
| 12:50 - 14:40 | 106 | Cystic fibrosis: clinical problems and microbiology in adults | Thematic Poster Session |
| 12:50 - 14:40 | 107 | Cystic fibrosis: clinical problems, genetics and microbiology in children | Thematic Poster Session |
| 12:50 - 14:40 | 108 | The burden of respiratory infections in children | Thematic Poster Session |
| 12:50 - 14:40 | 109 | Paediatric respiratory epidemiology: new understandings of lung function, disorders of prematurity and chronic airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 110 | Paediatric bronchology | Thematic Poster Session |
| 12:50 - 14:40 | 111 | Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles | Thematic Poster Session |
| 12:50 - 14:40 | 112 | Airway calibre, airway challenge and assessment of oxygenation | Thematic Poster Session |
| 12:50 - 14:40 | 113 | Exercise, physiotherapy techniques and assessment methods in COPD and asthma | Thematic Poster Session |
| 12:50 - 14:40 | 114 | Exercise and physiotherapy in non-COPD conditions and in the assessment of healthy subjects | Thematic Poster Session |
| 12:50 - 14:40 | 115 | Assessment methods involved in the physiotherapy treatment in different patient populations | Thematic Poster Session |
| 12:50 - 14:40 | 116 | Aspects of physiotherapy in various clinical conditions and settings | Thematic Poster Session |
| 12:50 - 14:40 | 117 | Respiratory nursing care: assessment, interventions and education | Thematic Poster Session |
| 12:50 - 14:40 | 118 | Genetics and genomics of lung disease | Thematic Poster Session |
| 13:00 - 14:30 | 119 | European Respiratory Review: what's hot in pulmonary medicine | Symposium |
| 13:00 - 14:30 | 120 | How to produce top quality ERS Guidelines | Symposium |
| 13:00 - 14:00 | 127 | ME4 Nuts and bolts of cardiopulmonary exercise testing (CPET): theory, guidelines and practice | Meet the expert |
| 13:00 - 14:00 | 128 | ME5 What's new in sarcoidosis management? | Meet the expert |
| 13:00 - 14:00 | 129 | ME3 Biomarkers for fibrotic lung disease – new clinical benchmarks from the lab? | Meet the expert |
| 13:00 - 14:00 | 130 | ME1 Respiratory evaluation and management of neuromuscular diseases | Meet the expert |
| 13:00 - 14:00 | 131 | ME2 Non-ventilatory aspects affecting the outcome of mechanical ventilation | Meet the expert |
| 13:15 - 14:30 | 132 | Perspectives in the management of challenging sleep disordered breathing - interactive session with clinical cases | Practical Workshop |
| 13:15 - 14:30 | 133 | The challenges and measures in home ventilation | Practical Workshop |
| 13:15 - 14:30 | 134 | Clinical challenges in ambulatory oxygen for COPD patients: a practical training course | Practical Workshop |
| 13:15 - 14:30 | 135 | Endoscopic lung volume reduction & newest clinical data | Practical Workshop |
| 14:30 - 16:50 | 137 | Educational skills workshop 3: Endoscopic lung-volume reduction and endosonography | Educational Workshop |
| 14:45 - 16:45 | 138 | Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I | Session |
| 14:45 - 16:45 | 139 | Noninvasive respiratory support for neonates: are we there yet? | Hot topics |
| 14:45 - 16:45 | 140 | Immunopathology of COPD: contribution of advancements of new therapeutic agents | Symposium |
| 14:45 - 16:45 | 141 | Which treatment other than chemotherapy for stage IV NSCLC? | Symposium |
| 14:45 - 16:45 | 142 | The upper airway in sleep-disordered breathing | Symposium |
| 14:45 - 16:45 | 143 | Bronchoconstriction under construction: work-related lung disease and how it's diagnosed | Symposium |
| 14:45 - 16:45 | 144 | New insights in the assessment of physical activity in daily life in patients with COPD, asthmatics and smokers | Oral Presentation |
| 14:45 - 16:45 | 145 | New perspectives of lung function assessment in children | Oral Presentation |
| 14:45 - 16:45 | 146 | Viral infections: what is new? | Oral Presentation |
| 14:45 - 16:45 | 147 | Pulmonary circulation: basic science | Oral Presentation |
| 14:45 - 16:45 | 148 | New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) | Oral Presentation |
| 14:45 - 16:45 | 149 | Fundamental biology of malignant pleural effusions | Oral Presentation |
| 14:45 - 16:45 | 150 | Genetic factors in airway development and disease | Oral Presentation |
| 14:45 - 16:45 | 151 | COPD diagnosis | Poster Discussion |
| 14:45 - 16:45 | 152 | Environment and lifestyle: associations with respiratory disease | Poster Discussion |
| 14:45 - 16:45 | 153 | Murine models of lung immunology | Poster Discussion |
| 14:45 - 16:45 | 154 | New drugs in respiratory medicine | Poster Discussion |
| 14:45 - 16:45 | 155 | Tuberculosis and latent tuberculosis infection in subpopulations | Poster Discussion |
| 14:45 - 16:45 | 156 | Asthma, allergy and lung function: natural history and risk factors in longitudinal studies | Poster Discussion |